|
Feb 13
|
Analysts Estimate Indivior PLC (INDV) to Report a Decline in Earnings: What to Look Out for
|
|
Feb 12
|
Karyopharm to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025
|
|
Jan 23
|
Verve Therapeutics (VERV) Moves 18.7% Higher: Will This Strength Last?
|
|
Jan 13
|
Karyopharm Announces Preliminary Unaudited 2024 Revenue and 2025 Objectives
|
|
Jan 2
|
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
|
Jan 2
|
Karyopharm Announces the Appointment of Lori Macomber as Chief Financial Officer
|